Can You Rebuild Joint Cartilage? The ‘Regeneration Signal’ Behind Urolithin B
HomeThe Energy Code › Episode

Can You Rebuild Joint Cartilage? The ‘Regeneration Signal’ Behind Urolithin B

15:38 Feb 6, 2026
About this episode
Ever stand up after hours at a desk and your knees sound like a rusty hinge? Or finish a weekend run and feel like your joints mailed you a strongly worded complaint by Tuesday?   In this Deep Dive, we unpack a 2025 paper from Discovery Medicine titled “Urolithin B promotes meniscal regeneration and prevents the development of osteoarthritis in mice.” The headline is big: not just less inflammation or less pain signaling, but actual meniscus repair signals in a disease model that normally accelerates joint breakdown.   We break down what Urolithin B is, why food sources aren’t reliable for most people, and how this molecule appears to flip joint cells from destruction mode to construction mode by suppressing inflammatory cytokines and tissue-chewing enzymes (like MMP-13) while boosting cartilage-building programs (like SOX9, collagen, and VEGF). We also connect the mechanism to the real-world “why” behind delivering Urolithin B directly (as discussed in the episode). - Article Discussed in Episode: Urolithin B Promotes Meniscal Regeneration and Prevents the Development of Osteoarthritis in Mice - Key Quotes From Dr. Mike: “(Urolithin B) is tackling what many would call the holy grail of joint health… regeneration.” “(Urolithin B) literally flipped the switch from a catabolic breakdown state to an anabolic build-up state.” “You’re not masking a symptom, you’re trying to reboot the regenerative machinery.” “Defend, protect, and rebuild all in one molecule." (In regards to Urolithin B) - Key points The big promise: regeneration — not just symptom relief. What Urolithin B is: a gut-derived metabolite from ellagic-acid-rich foods (pomegranate, walnuts, berries). Why diet isn’t enough for many: large portion of people may be low/non-producers due to microbiome variability. Meniscus 101: fibrocartilage “shock absorber” between femur and tibia; when it fails, OA risk rises fast. Current standard care problem: many options manage symptoms more than they restore tissue. In vitro findings: Urolithin B was non-toxic and calmed IL-1?–triggered inflammatory signaling. Stops the demolition crew: reduced destructive ECM enzymes (highlighted: MMP-13, ADAMTS enzymes). Starts the construction crew: increased cartilage matrix building
Select an episode
0:00 0:00